Purchase Order 75D30123P15899
- Not listed
- The Centers for Disease Control and Prevention (CDC) awarded a $93,496 purchase order to Roche Diagnostics Corporation for the delivery of Roche COBAS C6800/AMPLIPREP/CAPTAQ systems. This firm fixed price contract will provide the CDC's Pittsburgh location with laboratory equipment and supplies to support its disease testing and prevention efforts. Roche will deliver the requested products to the CDC site in Castleton, Indiana by October 25, 2023. No subcontractors or set aside designations were...
- The Centers for Disease Control and Prevention (CDC) awarded a $144,511 purchase order to Roche Diagnostics Corporation for reagents and laboratory supplies. As the prime contractor, Roche will provide the requested products to support CDC's disease prevention and health promotion efforts. The firm fixed price contract has a one year period of performance starting in September 2023. No subcontractors or set aside designations were indicated. The award falls under HHS-CDC's broader public...
- Roche Diagnostics Corporation was awarded a firm fixed-price purchase order valued at $572,044.24 by the Centers for Disease Control and Prevention (CDC) Pittsburgh for maintenance services on COBAS HIV equipment with operations support. The contract, awarded on July 17, 2024, carries an ultimate completion date of September 4, 2028, and will be performed in Castleton, Indiana. This award represents a non-competitive procurement with no set-aside designation, reflecting Roche's established...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, laboratory instruments, and associated products and services. The $113,563 contract provides ICF laboratory equipment and maintenance for the CDC's Pittsburgh location. This award is not designated as a set-aside. Roche Diagnostics has received numerous federal contract awards from agencies including the Department...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm-fixed price purchase order to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The $143,672.81 contract is for ROCHE REAGENTS AND SUPPLIES with a completion date of December 31, 2018. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies,...
- This $139,966.72 firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the provision of reagent testing supplies and does not have a set-aside designation. Roche Diagnostics has previously received awards from various federal agencies, including the Department of...
- This is a federal contract award to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract is for the maintenance of COBAS4800 and COBAS6800 equipment, with a total ceiling value of $130,151.30. The award was made by the Centers for Disease Control and Prevention (CDC) Pittsburgh, a civilian federal agency. The contract is a Delivery Order with a Firm Fixed Price...
- This is a $144,721.10 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation for laboratory supplies. The contract has no set-aside designation. Roche Diagnostics Corporation is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. Roche has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and...
- This is a federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the purchase of COBAS PURE C303/E402 clinical chemistry analyzers and associated reagents and supplies. The $460,000.00 firm fixed price contract was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh on April 24, 2023, with an ultimate completion date of December 31, 2023. The contract has no set-aside designation. Roche Diagnostics is a foreign-owned,...
- This is a $86,944 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for a ROCHE SERVICE AGREEMENT with a period of performance through September 2024. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies,...
The Centers for Disease Control and Prevention (CDC) Atlanta awarded a $150,782.40 firm fixed-price purchase order to Roche Diagnostics Corporation on April 1, 2023, for diagnostic services and support under a service agreement structure. The contract extends through March 31, 2027, with performance occurring at Roche's facility in Chamblee, Georgia. This award represents a direct procurement without set-aside designation, reflecting open competition in the federal diagnostic marketplace. As a foreign-owned manufacturer headquartered in Indianapolis, Indiana, Roche Diagnostics specializes in in vitro diagnostic equipment, laboratory instruments, reagents, and associated medical products—capabilities that align directly with the CDC's laboratory and disease detection operations. This purchase order constitutes a child contract within Roche Diagnostics' broader federal contracting portfolio, which includes multiple indefinite delivery contracts and blanket purchase agreements with the Department of Veterans Affairs, Defense Health Agency, and other federal healthcare entities. The company's established track record delivering molecular diagnostic analyzers, histology staining systems, immunochemistry platforms, and comprehensive maintenance services positions it as a primary supplier of advanced diagnostic capabilities across the federal healthcare sector. The CDC award reflects sustained demand for Roche's diagnostic technologies and underscores the company's significant presence in supporting critical laboratory operations across civilian federal healthcare agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00007 | Exercise an Option | $39.5k | 3/25/26 | |
| P00006 | Supplemental Agreement for work within scope | $0 | 3/17/26 | |
| P00005 | Other Administrative Action | $0 | 5/14/25 | |
| P00004 | Exercise an Option | $39.5k | 3/31/25 | |
| P00003 | Supplemental Agreement for work within scope | ($45k) | 7/28/24 |